Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hypnoanalgesia for Dermatological Surgery in Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04707014
Recruitment Status : Completed
First Posted : January 13, 2021
Last Update Posted : January 13, 2021
Sponsor:
Information provided by (Responsible Party):
JUANA MARIA PELAEZ PEREZ, Complejo Hospitalario de Toledo

Brief Summary:
This randomized clinical trial will evaluate the effect of hypnosedation on the need of sedation and analgesia in a pediatric population undergoing dermatological surgery, both during the procedure, and 24 hours after surgery. In addition, a secondary objetive is to evaluate the effect by specific age groups.

Condition or disease Intervention/treatment Phase
Anesthesia Behavioral: Hypnosis Behavioral: Attention-distracting techniques Not Applicable

Detailed Description:
In this clinical trial, pediatric patients scheduled for removal of benign skin lesions in a single center willbe randomised to receive hypnosis (intervention group) or attention-distracting techniques (control group). Endpoints will be the sedative dose (propofol) during surgery, and the need for analgesia (paracetamol and others) immediately after surgery (recovery) and after 24 hours. Randomization will be systematic in blocks depending on the day the surgery is programmed. Hypnosis will be delivered by an experienced anesthesist trained in the technique. Patients and families will be informed of the special treatment during surgery, but will be unaware of whether the patients are experiencing distraction or hypnosis techniques. Distraction is already a useful technique, and it is expected that patients will be satisfied with the procedure; however, the hypothesis to be tested is that hypnosis reduces the need for sedation and analgesia compared to distraction techniques, as well as improves satisfaction.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 28 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:

Patients are randomly distributed to one of the following groups:

Intervention group: Technique of rapid conversational hypnosis, with focus on therapeutic suggestion (guiding the patient into a hypnotic trance), adapted to child's cognitive development. Induction with hypnotic suggestion focuses and accompanies the child's body sensations and allows their active participation. After standard sedation, therapeutic suggestion is maintained throughout the surgery and in the post-hypnotic period before awakening.

Control group: High-tech distraction technique (Apple®), passive and chosen by the child, either an animated video or his or her favourite music. After standard intravenous sedation, the child is taken to the operating theatre to watch his or her favourite video or music and this is maintained throughout the procedure.

Masking: Single (Outcomes Assessor)
Masking Description: Different investigators are assigned to each phase of the study, with one designated as responsible for recruitment (MQD), another for intervention and control (JMPP), and another for subsequent evaluation in the post-anaesthesia recovery unit (URPA) and at 24 hours (responsible nursing staff).
Primary Purpose: Other
Official Title: Effectiveness of Hypnoanalgesia for Dermatological Surgery in Children: Randomised Clinical Trial
Actual Study Start Date : November 1, 2017
Actual Primary Completion Date : April 15, 2018
Actual Study Completion Date : April 30, 2018

Arm Intervention/treatment
Placebo Comparator: Attention-Distraction techniques
A high-tech distraction technique (Apple®), passive and chosen by the child, either an animated video or his or her favourite music. After standard intravenous sedation, the child is taken to the operating theatre to watch his or her favourite video or music and this is maintained throughout the procedure.
Behavioral: Attention-distracting techniques
i-pad with movies, games and music

Experimental: HIPNOSIS GROUP
A technique of rapid conversational hypnosis, with focus on therapeutic suggestion (guiding the patient into a hypnotic trance), adapted to the child's cognitive development. Induction with hypnotic suggestion focuses and accompanies the child's body sensations and allows their active participation. After standard sedation, therapeutic suggestion is maintained throughout the surgery and in the post-hypnotic period before awakening.
Behavioral: Hypnosis
Rapid conversational hypnosis
Other Names:
  • Hypnoanalgesia
  • Hypnosedation




Primary Outcome Measures :
  1. Total dose of propofol in mg/kg [ Time Frame: During surgery (Intra-operative) ]
    Measured in mg/kg weight

  2. Total dose of propofol in mg [ Time Frame: During surgery (Intra-operative) ]
    Measured in total mg

  3. Additional need for opioids during surgery [ Time Frame: During surgery (Intra-operative) ]
    Yes/no


Secondary Outcome Measures :
  1. Pain intensity in older children post-operative [ Time Frame: Immediately post-operative while on recovery unit ]
    0-10 visual analogue scale (VAS) administered by a blinded nurse, with higher values indicating higher levels of pain

  2. Pain intensity in younger children post-operative [ Time Frame: Immediately post-operative while on recovery unit ]
    0-10 Faces Pain Scale - Revised (FPS-r) administered by a blinded nurse, with higher values indicating higher levels of pain

  3. Pain intensity in older children after 24 hours [ Time Frame: 24 hours after discharge ]
    0-10 visual analogue scale (VAS) administered over the phone by a blinded nurse, with higher values indicating higher levels of pain

  4. Pain intensity in younger children after 24 hours [ Time Frame: 24 hours after discharge ]
    0-10 Faces Pain Scale - Revised (FPS-r) administered over the phone by a blinded nurse, with higher values indicating higher levels of pain

  5. Analgesic need [ Time Frame: 24 hours after discharge ]
    Recorded by a blinded nurse at reanimation unit as yes/no

  6. Analgesic needs [ Time Frame: 24 hours after discharge ]
    Recorded by a blinded nurse by telephone call as yes/no


Other Outcome Measures:
  1. Degree of satisfaction with the procedure [ Time Frame: 24 hours after discharge ]
    Validated survey with score 1-10 administered at the time of discharge to children and their guardians.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   5 Years to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. A class I or II of anaesthetic risk according to the American Society of Anesthesiologists,
  2. to be in a percentile between P3 and P97 in weight and height,
  3. without known drug allergies, and
  4. having fasted 6 hours for solids and 2 hours for water.

Exclusion Criteria:

  1. Children with diagnosed mental retardation or attention deficit,
  2. behavioural disorders,
  3. previous treatment with hypnosis,
  4. history of neurological pathology or psychomotor retardation,
  5. previous pain-related pathology,
  6. obstructive sleep apnoea syndrome (OSAS)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04707014


Locations
Layout table for location information
Spain
Complejo Hospitalario Toledo
Toledo, Spain, 45002
Sponsors and Collaborators
Complejo Hospitalario de Toledo
Investigators
Layout table for investigator information
Principal Investigator: Juana Maria PELAEZ PEREZ, PH Complejo Hospitalario Toledo
  Study Documents (Full-Text)

Documents provided by JUANA MARIA PELAEZ PEREZ, Complejo Hospitalario de Toledo:
Informed Consent Form  [PDF] March 15, 2019

Publications:
Layout table for additonal information
Responsible Party: JUANA MARIA PELAEZ PEREZ, Anesthesiologist, Complejo Hospitalario de Toledo
ClinicalTrials.gov Identifier: NCT04707014    
Other Study ID Numbers: CHT00028
First Posted: January 13, 2021    Key Record Dates
Last Update Posted: January 13, 2021
Last Verified: January 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: Any document upon reasonable request to the PI.
Supporting Materials: Study Protocol
Statistical Analysis Plan (SAP)
Informed Consent Form (ICF)
Time Frame: Up to 1 year after publication
Access Criteria: Justified interest in data. By e-mail to PI

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by JUANA MARIA PELAEZ PEREZ, Complejo Hospitalario de Toledo:
analgesia
anxiety
pain
paediatric surgery
dermatology
Hypnosis
Nervous System Diseases Central
Hypnotics and Sedatives
Nervous System Depressants
Physiological Effects of Drugs